75 related articles for article (PubMed ID: 951859)
1. Metabolic changes in diabetic uremic patients on hemodialysis.
Avram MM; Lipner HI; Sadiqali R; Iancu M; Gan AC
Trans Am Soc Artif Intern Organs; 1976; 22():412-9. PubMed ID: 951859
[TBL] [Abstract][Full Text] [Related]
2. Response of plasma immunoreactive active renin, inactive renin, plasma renin activity, and aldosterone to hemodialysis in patients with diabetic nephropathy.
Sasamura H; Suzuki H; Takita T; Hayashi M; Ohno J; Shirai T; Saruta T
Clin Nephrol; 1990 Jun; 33(6):288-92. PubMed ID: 2198118
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
5. Renin, growth hormone and insulin in hemodialyzed uremic diabetics.
Avram MM
Artif Organs; 1978 Nov; 2(4):382-5. PubMed ID: 743011
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of arginine- and hypoglycemia- induced growth hormone release by acetate in dialyzed patients.
Schmitz O; Hansen AP; Hansen HE; Orskov H
Clin Nephrol; 1982 Feb; 17(2):70-6. PubMed ID: 7067169
[TBL] [Abstract][Full Text] [Related]
7. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
8. Serum reverse T3 assay for predicting glucose intolerance in uremic patients on dialysis therapy.
De Marchi S; Cecchin E; Villalta D; Tesio F
Clin Nephrol; 1987 Apr; 27(4):189-98. PubMed ID: 3581526
[TBL] [Abstract][Full Text] [Related]
9. Serum insulin and insulin-like growth factor binding protein-1 levels in adult patients undergoing peritoneal dialysis.
Iglesias P; Grande C; Méndez J; Fernandez-Reyes MJ; Bajo MA; Selgas R; Díez JJ
Adv Perit Dial; 1996; 12():71-6. PubMed ID: 8865877
[TBL] [Abstract][Full Text] [Related]
10. Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.
Ersoy FF; Karayalcin U; Karayalcin B; Sapan M; Bozcuk H; Süleymanlar G; Yakupoglu G
Adv Perit Dial; 1995; 11():119-22. PubMed ID: 8534683
[TBL] [Abstract][Full Text] [Related]
11. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
Alvestrand A; Mujagic M; Wajngot A; Efendic S
Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
[TBL] [Abstract][Full Text] [Related]
12. Clinical course in insulin-dependent diabetics undergoing hemodialysis.
Zander E; Schulz B; Beckert R; Seidlein I
Exp Clin Endocrinol; 1985 Feb; 85(1):105-12. PubMed ID: 3987829
[TBL] [Abstract][Full Text] [Related]
13. Glucose, insulin and glucagon response to intravenous glucose load in patients on chronic hemodialysis.
Shasha SM; Nusem D; Kanter Y; Weiner F
Isr J Med Sci; 1988 Jan; 24(1):15-9. PubMed ID: 3279011
[TBL] [Abstract][Full Text] [Related]
14. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
Raskin P; Fujita Y; Unger RH
J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a phosphorous-31 magnetic resonance spectroscopy study.
Perseghin G; Fiorina P; De Cobelli F; Scifo P; Esposito A; Canu T; Danna M; Gremizzi C; Secchi A; Luzi L; Del Maschio A
J Am Coll Cardiol; 2005 Sep; 46(6):1085-92. PubMed ID: 16168295
[TBL] [Abstract][Full Text] [Related]
16. Early deposition of aluminum in bone in diabetic patients on hemodialysis.
Andress DL; Kopp JB; Maloney NA; Coburn JW; Sherrard DJ
N Engl J Med; 1987 Feb; 316(6):292-6. PubMed ID: 3807961
[TBL] [Abstract][Full Text] [Related]
17. [Diabetes in hemodialysis: study of differential factors].
Sanz París A; Lou Arnal LM; Gutiérrez Colón JA; Alvarez Lipe A; Albero Gamboa R
An Med Interna; 1998 Apr; 15(4):183-8. PubMed ID: 9608060
[TBL] [Abstract][Full Text] [Related]
18. Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose.
Abe M; Kaizu K; Matsumoto K
Ther Apher Dial; 2007 Aug; 11(4):280-7. PubMed ID: 17661834
[TBL] [Abstract][Full Text] [Related]
19. Abnormal serum growth hormone response to exercise in juvenile diabetics.
Hansen AP
J Clin Invest; 1970 Aug; 49(8):1467-78. PubMed ID: 5431658
[TBL] [Abstract][Full Text] [Related]
20. [Has the incidence of end-stage renal disease increased in diabetic patients? A center-based longitudinal study over 10 years].
Van Landeghem MA
Med Klin (Munich); 2005 May; 100(5):241-5. PubMed ID: 15902377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
